News
-
Researchers at Maastricht University's R&D Group VitaK and the University of North Carolina at Chapel Hill (USA) discovered two new mutations in the enzyme GGCX, which activates coagulation factors in the blood.
-
Dr Hylke Dijkstra has been appointed as the new editor-in-chief of the international peer-reviewed journal Contemporary Security Policy published by Taylor and Francis.
-
Scientists from Maastricht University (UM) have investigated a possible link between stress in fat cells and the probability of regaining weight after weight loss (the yo-yo effect).
-
During the annual Dies Natalis of Maastricht University on Monday 11 January four FASoS students received a prize for their bachelor’s/master’sthesis. They each won €500,- and a certificate.
-
Ton Hartlief will be appointed Advocate-general at the Supreme Court of the Netherlands.
-
An alternative to the 'hard spinal board' used to transport patients with potential spinal injuries has been developed as part of a PhD programme at Maastricht University.
-
Call for papers – Extension of Deadline and Reminder! The deadline for the submission of papers is moved to 31 january 2016!
-
Researchers at Maastricht University Medical Center (Maastricht, Netherlands), Máxima Medical Center (Veldhoven, Netherlands) and Athersys Inc. (Cleveland, USA) have shown that stem cell therapy can prevent brain damage in premature infants.
-
A study by Julianne van der Berg and colleagues at Maastricht University has shown that each extra hour of sitting is associated with a 22% increased risk of developing type 2 diabetes.
